Literature DB >> 7373050

Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.

H Milgrom, J G Curd, R A Kaplan, H J Müller-Eberhard, J H Vaughan.   

Abstract

The classical pathway of complement (C) is activated in several diseases, and this activation characteristically involves the activation of C4, the fourth component of C. Since activation of C4 ultimately produces the polypeptide fragment C4d, we have applied immunoelectrophoresis in gels containing antibodies that precipitate C4d and C4 (rocket immunoelectrophoresis) as a means of detecting and quantitating C4 activation. Plasma C4 produced a single precipitin line after rocket immunoelectrophoresis, whereas plasma containing C4d produced two precipitin lines corresponding to C4d and C4. The areas enclosed by the respective precipitin line(s) were quantitated by planimetry and approximated the amounts of C4d and C4 present in the specimen. The ratio of the areas of C4d/C4 as measured in this analysis correlated significantly with the in vivo metabolism of radiolabeled C4. Our method detected C4d in the plasmas of some patients with rheumatoid arthritis, hereditary angioedema, systemic lupus erythematosus, or chronic urticaria with hypocomplementemia. These studies indicated that determination of the C4d/C4 ratio is useful in the evaluation of in vivo C activation and also may be applicable to the study and management of diseases associated with C activation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Cold-dependent activation of complement: recognition, assessment, and mechanism.

Authors:  K P Mathews; R A Mentyka; S L Chambers; T E Hugli; J H Herschbach; B L Zuraw
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

Review 3.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

4.  Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.

Authors:  V A Makinde; G Senaldi; A S Jawad; H Berry; D Vergani
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

5.  Complement in type 1 (insulin-dependent) diabetes.

Authors:  G Senaldi; B A Millward; M J Hussein; D Pyke; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

Review 6.  Methods to detect and quantitate complement activation.

Authors:  N R Cooper; G R Nemerow; J T Mayes
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.

Authors:  E T Davies; B A Nasaruddin; A Alhaq; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

8.  Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.

Authors:  G Senaldi; V A Makinde; D Vergani; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Association of rheumatoid factor with complement activation in rheumatoid arthritis and other diseases.

Authors:  P A Reyes; J G Maluf; J G Curd; J H Vaughan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

10.  IgG and IgM rheumatoid factor in active seronegative nodular rheumatoid arthritis and in children with benign rheumatoid nodules.

Authors:  D L Robbins; T L Moore; S M Naguwa
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.